171 related articles for article (PubMed ID: 12574810)
21. Impact of a pharmacist-led warfarin self-management program on quality of life and anticoagulation control: a randomized trial.
Verret L; Couturier J; Rozon A; Saudrais-Janecek S; St-Onge A; Nguyen A; Basmadjian A; Tremblay S; Brouillette D; de Denus S
Pharmacotherapy; 2012 Oct; 32(10):871-9. PubMed ID: 23033226
[TBL] [Abstract][Full Text] [Related]
22. Pharmacogenetics-based warfarin dosing algorithm decreases time to stable anticoagulation and the risk of major hemorrhage: an updated meta-analysis of randomized controlled trials.
Wang ZQ; Zhang R; Zhang PP; Liu XH; Sun J; Wang J; Feng XF; Lu QF; Li YG
J Cardiovasc Pharmacol; 2015 Apr; 65(4):364-70. PubMed ID: 25551322
[TBL] [Abstract][Full Text] [Related]
23. [Current issues in the initial phase of warfarin therapy].
Squizzato A; Steidl L; Ageno W
Recenti Prog Med; 2005 Dec; 96(12):612-5. PubMed ID: 16496748
[TBL] [Abstract][Full Text] [Related]
24. Influence of Kidney Transplant Status on Warfarin Dose, Anticoagulation Control, and Risk of Hemorrhage.
Yanik MV; Irvin MR; Beasley TM; Jacobson PA; Julian BA; Limdi NA
Pharmacotherapy; 2017 Nov; 37(11):1366-1373. PubMed ID: 28949423
[TBL] [Abstract][Full Text] [Related]
25. Warfarin dose assessment every 4 weeks versus every 12 weeks in patients with stable international normalized ratios: a randomized trial.
Schulman S; Parpia S; Stewart C; Rudd-Scott L; Julian JA; Levine M
Ann Intern Med; 2011 Nov; 155(10):653-9, W201-3. PubMed ID: 22084331
[TBL] [Abstract][Full Text] [Related]
26. Pilot study of a novel patient self-management program for warfarin therapy using venipuncture-acquired international normalized ratio monitoring.
Simmons BJ; Jenner KM; Delate T; Clark NP; Kurz D; Witt DM
Pharmacotherapy; 2012 Dec; 32(12):1078-84. PubMed ID: 23112110
[TBL] [Abstract][Full Text] [Related]
27. Hematology consult: high-sensitivity warfarin genotype.
Schwer C; Lamana S; Dasanu CA
Conn Med; 2013; 77(10):581-5. PubMed ID: 24367840
[TBL] [Abstract][Full Text] [Related]
28. Practical application of the 10-mg warfarin initiation nomogram.
Wells PS; Le Gal G; Tierney S; Carrier M
Blood Coagul Fibrinolysis; 2009 Sep; 20(6):403-8. PubMed ID: 19521238
[TBL] [Abstract][Full Text] [Related]
29. Warfarin sensitivity after mechanical heart valve replacement.
Rose JP; Rihn TL; Long SF
Pharmacotherapy; 1998; 18(4):856-9. PubMed ID: 9692661
[TBL] [Abstract][Full Text] [Related]
30. Factors affecting warfarin therapy following cardiac valve surgery.
Lee J; Lee B; Kim K; Ahn H; Suh O; Lee M; Shin W
Ann Pharmacother; 2002 Dec; 36(12):1845-50. PubMed ID: 12452742
[TBL] [Abstract][Full Text] [Related]
31. Age and body weight adjusted warfarin initiation program for ischaemic stroke patients.
Yoo SH; Nah HW; Jo MW; Kang DW; Kim JS; Koh JY; Kwon SU
Eur J Neurol; 2009 Oct; 16(10):1100-5. PubMed ID: 19614967
[TBL] [Abstract][Full Text] [Related]
32. Assessment of warfarin dosing requirements after bariatric surgery in patients requiring long-term warfarin therapy.
Irwin AN; McCool KH; Delate T; Witt DM
Pharmacotherapy; 2013 Nov; 33(11):1175-83. PubMed ID: 23744816
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of warfarin initiation regimens in elderly inpatients.
O'Connell MB; Kowal PR; Allivato CJ; Repka TL
Pharmacotherapy; 2000 Aug; 20(8):923-30. PubMed ID: 10939553
[TBL] [Abstract][Full Text] [Related]
34. Pharmacogenetics-Based versus Conventional Dosing of Warfarin: A Meta-Analysis of Randomized Controlled Trials.
Shi C; Yan W; Wang G; Wang F; Li Q; Lin N
PLoS One; 2015; 10(12):e0144511. PubMed ID: 26672604
[TBL] [Abstract][Full Text] [Related]
35. Genotype-guided dosing versus conventional dosing of warfarin: A meta-analysis of 15 randomized controlled trials.
Yang T; Zhou Y; Chen C; Lu M; Ma L; Cui Y
J Clin Pharm Ther; 2019 Apr; 44(2):197-208. PubMed ID: 30593674
[TBL] [Abstract][Full Text] [Related]
36. Anticoagulation control in Sweden: reports of time in therapeutic range, major bleeding, and thrombo-embolic complications from the national quality registry AuriculA.
Wieloch M; Själander A; Frykman V; Rosenqvist M; Eriksson N; Svensson PJ
Eur Heart J; 2011 Sep; 32(18):2282-9. PubMed ID: 21616951
[TBL] [Abstract][Full Text] [Related]
37. Initiating warfarin therapy: 5 mg versus 10 mg.
Eckhoff CD; Didomenico RJ; Shapiro NL
Ann Pharmacother; 2004 Dec; 38(12):2115-21. PubMed ID: 15522981
[TBL] [Abstract][Full Text] [Related]
38. Multicenter evaluation of six methods for predicting warfarin maintenance-dose requirements from initial response.
Sawyer WT; Poe TE; Canaday BR; Weiner JS; Williams DM; Webb CE; Ellison MJ
Clin Pharm; 1985; 4(4):440-6. PubMed ID: 3899472
[TBL] [Abstract][Full Text] [Related]
39. [Use of warfarin and low range INR in the prevention of recurrent venous thrombosis].
Quintero J; Torres E; Diez-Ewald M; Arteaga-Vizcaíno M; Vizcaíno G; León M; Rodríguez Z; Fernández N
Invest Clin; 2011 Sep; 52(3):230-8. PubMed ID: 21950194
[TBL] [Abstract][Full Text] [Related]
40. Thrombosis prevention trial: randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk. The Medical Research Council's General Practice Research Framework.
Lancet; 1998 Jan; 351(9098):233-41. PubMed ID: 9457092
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
